TG Therapeutics
TGTX
#2359
Rank
NZ$14.28 B
Marketcap
NZ$93.33
Share price
-0.39%
Change (1 day)
54.54%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): NZ$0.22 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are NZ$0.61 Billion. , an increase over its 2024 earnings that were of NZ$87.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.23 B169.57%
2024 NZ$87.1 M93.76%
2023 NZ$44.95 M-113.65%
2022 -NZ$0.33 Billion-45.06%
2021 -NZ$0.6 Billion25.42%
2020 -NZ$0.48 Billion62.93%
2019 -NZ$0.3 Billion-3.34%
2018 -NZ$0.31 Billion46.05%
2017 -NZ$0.21 Billion48.38%
2016 -NZ$0.15 Billion29.09%
2015 -NZ$0.11 Billion12.99%
2014 -NZ$96.03 Million180.92%
2013 -NZ$34.19 Million
2009 -NZ$3.11 Million-59.85%
2008 -NZ$7.73 Million
2006 -NZ$17.51 Million-48.34%
2005 -NZ$33.89 Million215.12%
2004 -NZ$10.76 Million29.1%
2003 -NZ$8.34 Million159.59%
2002 -NZ$3.21 Million
2000 -NZ$5.51 Million12.38%
1999 -NZ$4.91 Million7.69%
1998 -NZ$4.56 Million-49.02%
1997 -NZ$8.93 Million82.14%
1996 -NZ$4.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.41 B 76.86%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
NZ$1.52 B 551.19%๐Ÿ‡ฎ๐Ÿ‡ณ India